Escolar Documentos
Profissional Documentos
Cultura Documentos
ASSETS
Non-current assets
Property, plant and equipment
Capital work-in-progress
Investment in subsidiaries
Investment in shares
Other investment
Total non-current assets
Figures in Taka
Notes
2013
2012
5
6
7
8
9
6,348,183,516
2,026,083,847
143,069,376
56,363,666
8,573,700,405
4,268,926,361
2,061,905,242
63,070,376
18,363,123
30,592,153
6,442,857,255
10
11
12
13
2,657,779,255
1,142,685,421
167,985,236
240,262,887
4,208,712,799
12,782,413,204
1,986,744,883
843,231,267
148,951,592
331,292,974
3,310,220,716
9,753,077,971
14
15
16
17
353,023,430
157,477,414
249,496,624
5,535,117,143
6,295,114,611
282,418,750
157,955,917
206,609,359
4,423,495,722
5,070,479,748
18
19
20
21
202,530,242
473,840,609
477,306,667
1,153,677,518
175,366,283
272,041,423
225,000,000
1,000,000,000
1,672,407,706
Current liabilities
3,041,324,251
22
Short term bank loan
229,743,333
20
Long term loan - current portion
1,000,000,000
21
Non-convertible bond - current portion
64,986,063
23
Trade payables
263,876,962
24
Accruals
353,179,625
25
Provision and other liabilities
9,915,749
26
Unclaimed dividend
370,595,092
27
Provision for taxation
5,333,621,075
Total current liabilities
6,487,298,593
Total liabilities
12,782,413,204
Total equity and liabilities
The annexed notes 1 to 42 form an integral part of these financial statements.
1,812,605,178
133,333,333
46,041,266
272,566,529
335,627,045
7,907,075
402,110,091
3,010,190,517
4,682,598,223
9,753,077,971
Current assets
Inventories
Trade and other receivables
Advance, deposits and prepayments
Cash and cash equivalents
Total current assets
Total assets
EQUITY AND LIABILITIES
Equity attributable to equity holders of the company
Share capital
Revaluation surplus
Tax holiday reserve
Retained earnings
Total equity attributable to equity holders of the company
Non-current liabilities
Deferred liability-staff gratuity
Deferred tax liability
Long term loan - net of current portion
Non-convertible bond - net of current portion
Total non-current liabilities
Director
RENATA LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2013
Figures in Taka
2013
Penicillin Facility
Notes
Non-tax
holiday
units
Turnover
28
7,632,078,333 922,957,050
Cost of sales
29 (3,603,084,694) (554,951,551)
Gross Profit
4,028,993,639 368,005,499
Operating Expenses:
Administrative, selling and
distribution expenses
30 (1,802,842,910) (203,239,088)
Operating profit
2,226,150,729 164,766,411
Other income/(loss)
31
(762,817)
Gain/(loss) on disposal of
Property, plant and equipment 5.5
398,849
Finance Cost
32
(374,558,159) (44,895,390)
Profit before Contribution to WPPF 1,851,228,602 119,871,021
Contribution to WPPF
(88,153,743) (5,708,144)
Profit before tax
1,763,074,859 114,162,877
Tax expenses:
Current tax
27
(278,171,926) (14,127,656)
Deferred tax
19
(201,956,568)
Net profit after tax for the year
(480,128,494) (14,127,656)
1,282,946,366 100,035,221
Total of
Penicillin
Facility
Total
(1,929,645) (23,330,624)
1,403,394 16,967,919
-
(751,983)
651,411
(31,020)
620,391
(9,091,948)
7,875,971
(375,046)
7,500,925
398,849
(218,312)
(9,843,931) (429,297,480) (381,110,055)
8,527,382 1,979,627,005 1,807,596,438
(406,066) (94,267,953) (85,618,793)
8,121,316 1,885,359,052 1,721,977,645
620,391
(938,375)
(938,375)
6,562,550
Total
2012
3,764,204
(252,830)
1,393,928,731 1,247,275,330
33
39.38
35.34
Director